STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Century Therapeutics (NASDAQ: IPSC) announced that Chad Cowan, Ph.D., Chief Scientific Officer, will present at Chardan’s 9th Annual Genetic Medicines Conference on Tuesday, October 21, 2025 at 12:20 p.m. ET in New York.

A live webcast of the presentation will be available on Century’s Investors page at www.centurytx.com, and an archived replay will be accessible for at least 30 days after the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

PHILADELPHIA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases and cancer, today announced that Chad Cowan, Ph.D., Chief Scientific Officer of Century Therapeutics, will present at Chardan’s 9th Annual Genetic Medicines Conference on Tuesday, October 21, 2025, at 12:20 p.m. ET in New York, NY.

A live webcast of the presentation will be available on the Investors page of Century’s website at www.centurytx.com. An archived replay will be available for at least 30 days.

About Century Therapeutics
Century Therapeutics (NASDAQ: IPSC) is a clinical-stage biotechnology company advancing a pipeline of induced pluripotent stem cell (iPSC)-derived cell therapies with the potential to meaningfully address autoimmune diseases and cancer. The company’s therapies are derived from its iPSC cell foundry and leverage its novel immune evasion engineering technology, Allo-Evasion™. Century believes its approach to developing off-the-shelf cell therapies will expand patient access and provide advantages over existing cell therapies which will ultimately advance the course of care. For more information on Century Therapeutics, please visit www.centurytx.com and connect with us on LinkedIn.

For More Information:

Century Therapeutics
Douglas Carr
Senior Vice President, Finance
investor.relations@centurytx.com

JPA Health
Sarah McCabe
smccabe@jpa.com


FAQ

When will Century Therapeutics (IPSC) present at Chardan’s 9th Annual Genetic Medicines Conference?

Century Therapeutics (IPSC) will present on Tuesday, October 21, 2025 at 12:20 p.m. ET.

Who from Century Therapeutics will present at the October 21, 2025 Chardan conference?

Chad Cowan, Ph.D., Chief Scientific Officer of Century Therapeutics, will deliver the presentation.

How can investors watch the Century Therapeutics (IPSC) presentation on October 21, 2025?

A live webcast will be available on Century’s Investors page at www.centurytx.com.

Will Century Therapeutics’ (IPSC) presentation at Chardan be available after the event?

Yes. An archived replay will be available on the company website for at least 30 days after the presentation.

What topics will Century Therapeutics (IPSC) likely cover at the Chardan Genetic Medicines Conference on October 21, 2025?

The presentation is expected to cover Century’s work on iPSC-derived cell therapies for autoimmune diseases and cancer.
Century Therapeutics, Inc.

NASDAQ:IPSC

IPSC Rankings

IPSC Latest News

IPSC Latest SEC Filings

IPSC Stock Data

47.61M
62.49M
26.69%
41.9%
1.8%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
PHILADELPHIA